- Fund Type: Closed-End Fund
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: U.S.
H&Q Healthcare Investors
+ Add to WatchlistXHQHX:US
21.96 USD 0.12 0.54%As of 09:29:30 ET on 06/17/2013.
Snapshot for H&Q Healthcare Investors (XHQHX)
| Year To Date: | +23.58% | 3-Month: | +8.69% | 3-Year: | +24.96% | 52-Week Range: | 17.74 - 23.32 |
|---|---|---|---|---|---|---|---|
| 1-Month: | -2.92% | 1-Year: | +33.97% | 5-Year: | +11.96% | Beta vs BTK: | 0.69 |
Fund Profile & Information for XHQHX
H&Q Healthcare Investors is a diversified, closed-end management investment company incorporated in the USA. The Trust's objective seeks long-term capital appreciation. The Trust will invest 80% of its assets in health services and medical technology companies, that have significant potential for above-average growth.
| Inception Date: | 04-22-1987 | Telephone: | 1-617-772-8500 |
|---|---|---|---|
| Managers: | DANIEL R OMSTEAD | ||
| Web Site: | www.teklacap.com | ||
Fundamentals for XHQHX
| NAV | (on 2013-06-17) 21.96 |
|---|---|
| Assets (M) | (on 2013-06-17) 596.56 |
| Fund Leveraged | N |
| Minimum Investment | 0.00 |
| Minimum Subsequent Investment | 0.00 |
Dividends for XHQHX
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Quarter |
| Last Dividend Net | (on 2013-05-23) 0.42 |
| Dividend Yield (ttm) | 6.97 |
Fees & Expenses for XHQHX
| Front Load | 0.00 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 0.98 |
| Redemption Fee | 0.00 |
| 12b1 Fee | 0.00 |
| Expense Ratio | 1.42 |
Top Fund Holdings for XHQHX
Filing Date: 12/31/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| Gilead Sciences Inc | 1,039,942 | 38,191,870 | 7.703% |
| Regeneron Pharmaceuticals Inc | 210,044 | 35,932,227 | 7.248% |
| Celgene Corp | 403,533 | 31,766,118 | 6.407% |
| Biogen Idec Inc | 151,080 | 22,158,904 | 4.470% |
| Alexion Pharmaceuticals Inc | 231,115 | 21,680,897 | 4.373% |
| Puma Biotechnology Inc | 762,910 | 14,304,562 | 2.885% |
| Perrigo Co | 136,379 | 14,187,507 | 2.862% |
| Mylan Inc/PA | 501,580 | 13,783,418 | 2.780% |
| Merck & Co Inc | 296,620 | 12,143,623 | 2.449% |
| Hologic Inc | 561,739 | 11,251,632 | 2.269% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page